TCL Archive Recalcitrant Cancer Bill Heading To Senate May Face Hold in the Lame Duck Session November 16, 2012
TCL Archive Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market August 2, 2002
TCL Archive GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds April 21, 1989
TCL Archive “Absurd” Budget Cuts Would Devastate Cancer Program, Slash NCI Funds By $125 Million December 6, 1974